Your question leads to the area of Pharmacogenomics as well as into the field of Precision medicine or Personalised medicine. Here's the attached document on newer challenges in the management of hyperglycaemia in DM:
Thank Mr Tausif Alam ·, Mrs Fahimeh Kazemi , Mrs Ranjita Santra for all your response .
But my question is not about how the survival rate of sugar in the blood, or the reason for its survival for a long time. My question is why the impact of this on patients varies from person to person, I'm not in the field i hope that you will help me in the question and thank you in advance.
Consider the interdependence of "how" and "why", given that diabetes is not the result of a single cause (as I alluded earlier) nor all the diabetes patients are identical clones of each other who share identical life-long environment and circumstances.